MICOT PHARMA-B (02335) has been included in the stock connection mechanism (Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect) stock list.

MICOT PHARMA-B (02335) announced that, according to the announcements made by the Shanghai Stock Exchange and the Shenzhen Stock Exchange on September 4, 2026, and September 7, 2026, respectively, the company's H-shares have been included in the list of eligible stocks for the Stock Connect (Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect) mechanism, effective from September 7, 2026. After the shares are included in the Stock Connect mechanism, eligible investors in mainland China can buy and sell shares through the Shanghai Stock Exchange and the Shenzhen Stock Exchange. The company believes that the inclusion of its shares as eligible securities in the Stock Connect mechanism indicates market recognition of the company's investment value and growth prospects. The company expects that being included as eligible securities will help further expand the shareholder base, increase the trading liquidity of the shares, and in the long run, support the company's innovation-driven and sustainable growth.